The recent research work based on targeted delivery of Peptide Nucleic Acid (PNA) to kidneys using pH low insertion peptide (pHLIP) technology has been published in JCI Insights. The research work “Genetic deficiency or pharmacological inhibition of miR-33 protects from kidney fibrosis” was performed in collaboration with Dr. Carlos Fernández-Hernando at the Yale University School of Medicine.

---